<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367583">
  <stage>Registered</stage>
  <submitdate>11/12/2014</submitdate>
  <approvaldate>19/01/2015</approvaldate>
  <actrnumber>ACTRN12615000031561</actrnumber>
  <trial_identification>
    <studytitle>The Fluid Translation of Research into Practice Study - Discrete Choice Experiment (Survey) of Intensive Care clinicians preferences of resuscitation fluid.   </studytitle>
    <scientifictitle>Discrete choice experiment to understand what drives intensive care clinicians' choice of fluid type used for fluid resuscitation in intensive care patients</scientifictitle>
    <utrn />
    <trialacronym>Fluid TRIPS DCE</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Critical Illness</healthcondition>
    <healthcondition>Hypovolemia</healthcondition>
    <healthcondition>Fluid resuscitation</healthcondition>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Health service research</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The aim of this study is to define and understand the fundamental drivers of fluid resuscitation choice for critically ill patients. The study uses a scenario based survey of clinician preferences using the Discrete Choice Experiment (DCE) methodology.  The survey will be administered online via a secure database and will take each clinician approximately 20-30 minutes to complete.  The study period is anticipated to run for 2-3 months. </interventions>
    <comparator>Not applicable</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary objective of this study is to identify key attributes that have the largest influence on the choice of fluid used for resuscitation.

The statistical analysis of the DCE data will involve a mixed multinomial (randoms parameters) logit model (MMNL) using a panel size specification. </outcome>
      <timepoint>Within 6 months of completion of the Fluid TRIPS Study
Australian New Zealand Clinical Trials Registry, Number:ACTRN12613001172796 </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The secondary objective is to describe a willingness to spend threshold (by international region) where clinicians will switch from less expensive preparations to more expensive preparations.

The analysis will enable: 1) estimates of the marginal effect of each attribute, and respondent characteristic on choice of resuscitation fluid; 2) the relative tradeoff (or marginal rate of substitution) between attributes, in particular the calculation of clinician willingness to spend thresholds, and 3) predictions to be made of the preference for current resuscitation fluids.</outcome>
      <timepoint>Within 6 months of completion of the Fluid TRIPS Study  Australian New Zealand Clinical Trials Registry, Number:ACTRN12613001172796 </timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Intensive Care Clinician at participating hospital</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Convenience sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>16/03/2015</anticipatedstartdate>
    <actualstartdate>14/08/2015</actualstartdate>
    <anticipatedenddate />
    <actualenddate>30/12/2015</actualenddate>
    <samplesize>352</samplesize>
    <actualsamplesize>367</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>29/02/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>ACT,NSW,NT,QLD,SA,TAS,WA,VIC</recruitmentstate>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Chile</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Ireland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Japan</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Monaco</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>South Africa</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Arab Emirates</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States of America</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hong Kong</country>
      <state />
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>The George Institute for Global Health</primarysponsorname>
    <primarysponsoraddress>L13, 321 Kent Street
Sydney NSW 2000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>The George Institute for Global Health</fundingname>
      <fundingaddress>L13, 321 Kent Street
Sydney NSW 2000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Charities/Societies/Foundations</othercollaboratortype>
      <othercollaboratorname>Intensive Care Foundation</othercollaboratorname>
      <othercollaboratoraddress>Level 2, 10 Ievers Terrace
Carlton South
VIC AUSTRALIA 3053</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Hypotheses: The choice of fluid resuscitation preparations selected by clinicians is determined by short term considerations such as time to haemodynamic benefit and fluid volume required rather than by level of evidence, risk of adverse events or cost.
Objectives: The primary objective of this study is to identify the attributes that have the largest influence on the choice of fluid used for resuscitation. The secondary objective is to describe a willingness to spend threshold (by international region) where clinicians will switch from less expensive preparations to more expensive preparations.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney Local Health District Ethics Review Committee (RPAH Zone)</ethicname>
      <ethicaddress>Research Development Office
Suite 210A
RPAH Medical Centre
100 Carillon Avenue
NEWTOWN NSW 2042</ethicaddress>
      <ethicapprovaldate>8/05/2015</ethicapprovaldate>
      <hrec>EC00152</hrec>
      <ethicsubmitdate>8/01/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Colman Taylor</name>
      <address>The George Institute for Global Health 
L13,321 Kent Street
Sydney NSW 2000</address>
      <phone>+61 2 9657 0316</phone>
      <fax />
      <email>ctaylor@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Colman Taylor</name>
      <address>The George Institute for Global Health 
L13,321 Kent Street
Sydney NSW 2000</address>
      <phone>+61 2 9657 0316</phone>
      <fax />
      <email>ctaylor@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Colman Taylor</name>
      <address>The George Institute for Global Health
L13,321 Kent Street
Sydney NSW 2000</address>
      <phone>+61 2 9657 0316</phone>
      <fax />
      <email>ctaylor@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Kelly Thompson</name>
      <address>The George Institute for Global Health 
L13,321 Kent Street
Sydney NSW 2000</address>
      <phone />
      <fax />
      <email>kthompson@georgeinstitute.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>